First, Tuesday's market rally was really disgusting to everyone, but the good thing was to cover the gap of the day's upward gap and rule out the hidden danger of covering the gap in the market outlook.Second, the key areas mainly involve integrated circuits, biomedicine, new materials and other industries. Make good use of the 10 billion yuan integrated circuit design industry M&A fund and set up a 10 billion yuan biomedical industry M&A fund;Third, cultivate about 10 internationally competitive listed companies in the field;
It is worth noting that the action plan ranks biomedicine in the second place, and sets up a 10 billion biomedical industry M&A fund, which is basically the same as the status of integrated circuits. In addition, the action plan puts the merger of securities companies at the end, and its status has declined.On Tuesday, A-shares opened sharply higher and fell back, and walked out of the disgusting market, which was worse than stepping on the air. The highest point in the market was close to 3,500 points, and the result closed at 3,422.66.First, Tuesday's market rally was really disgusting to everyone, but the good thing was to cover the gap of the day's upward gap and rule out the hidden danger of covering the gap in the market outlook.
First, the plan mentioned that by 2027, we will strive to land a number of representative M&A cases in key industries, form a M&A transaction scale of 300 billion yuan, and activate total assets of over 2 trillion yuan;In the end, the A-share market has ushered in a positive trend. However, investors were like frightened birds after Tuesday's A-share surge and fall. They were already afraid of good news and didn't know whether to leave or stay. Personally, as long as the trend of A shares does not go bad, I will choose to stay.Second, the key areas mainly involve integrated circuits, biomedicine, new materials and other industries. Make good use of the 10 billion yuan integrated circuit design industry M&A fund and set up a 10 billion yuan biomedical industry M&A fund;
Strategy guide 12-13
Strategy guide
12-13